杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/29 | 2,273 | 2,331 | 2,267 | 2,331 | +54 | +2.4% | 435,900 |
2020/05/28 | 2,237 | 2,280 | 2,225 | 2,277 | +44 | +2% | 361,700 |
2020/05/27 | 2,192 | 2,235 | 2,181 | 2,233 | +18 | +0.8% | 329,000 |
2020/05/26 | 2,231 | 2,237 | 2,193 | 2,215 | -9 | -0.4% | 206,100 |
2020/05/25 | 2,194 | 2,230 | 2,184 | 2,224 | +51 | +2.3% | 233,300 |
2020/05/22 | 2,232 | 2,239 | 2,165 | 2,173 | -82 | -3.6% | 238,200 |
2020/05/21 | 2,212 | 2,256 | 2,181 | 2,255 | +58 | +2.6% | 390,500 |
2020/05/20 | 2,160 | 2,207 | 2,160 | 2,197 | +46 | +2.1% | 270,800 |
2020/05/19 | 2,187 | 2,197 | 2,133 | 2,151 | -37 | -1.7% | 261,600 |
2020/05/18 | 2,172 | 2,195 | 2,168 | 2,188 | +30 | +1.4% | 187,000 |
2020/05/15 | 2,177 | 2,205 | 2,138 | 2,158 | -23 | -1.1% | 266,900 |
2020/05/14 | 2,220 | 2,254 | 2,181 | 2,181 | -67 | -3% | 305,200 |
2020/05/13 | 2,243 | 2,283 | 2,225 | 2,248 | -22 | -1% | 589,900 |
2020/05/12 | 2,240 | 2,275 | 2,231 | 2,270 | +30 | +1.3% | 454,900 |
2020/05/11 | 2,206 | 2,243 | 2,206 | 2,240 | +15 | +0.7% | 173,700 |
2020/05/08 | 2,265 | 2,274 | 2,216 | 2,225 | -22 | -1% | 236,600 |
2020/05/07 | 2,226 | 2,264 | 2,224 | 2,247 | +21 | +0.9% | 353,900 |
2020/05/01 | 2,230 | 2,260 | 2,208 | 2,226 | -18 | -0.8% | 237,500 |
2020/04/30 | 2,318 | 2,333 | 2,242 | 2,244 | -78 | -3.4% | 405,500 |
2020/04/28 | 2,328 | 2,328 | 2,280 | 2,322 | -13 | -0.6% | 234,000 |
2020/04/27 | 2,372 | 2,391 | 2,330 | 2,335 | -50 | -2.1% | 290,000 |
2020/04/24 | 2,407 | 2,435 | 2,364 | 2,385 | +18 | +0.8% | 692,400 |
2020/04/23 | 2,310 | 2,379 | 2,310 | 2,367 | +76 | +3.3% | 557,500 |
2020/04/22 | 2,228 | 2,304 | 2,204 | 2,291 | +50 | +2.2% | 477,400 |
2020/04/21 | 2,264 | 2,278 | 2,212 | 2,241 | -43 | -1.9% | 222,100 |
2020/04/20 | 2,305 | 2,328 | 2,280 | 2,284 | -35 | -1.5% | 242,800 |
2020/04/17 | 2,288 | 2,338 | 2,283 | 2,319 | +44 | +1.9% | 574,400 |
2020/04/16 | 2,219 | 2,281 | 2,210 | 2,275 | +76 | +3.5% | 466,000 |
2020/04/15 | 2,229 | 2,229 | 2,173 | 2,199 | -23 | -1% | 215,900 |
2020/04/14 | 2,212 | 2,239 | 2,208 | 2,222 | -14 | -0.6% | 187,100 |
2020/04/13 | 2,212 | 2,236 | 2,184 | 2,236 | +33 | +1.5% | 257,700 |
2020/04/10 | 2,167 | 2,210 | 2,136 | 2,203 | +36 | +1.7% | 281,200 |
2020/04/09 | 2,175 | 2,180 | 2,121 | 2,167 | -19 | -0.9% | 404,700 |
2020/04/08 | 2,175 | 2,207 | 2,156 | 2,186 | -11 | -0.5% | 305,200 |
2020/04/07 | 2,232 | 2,259 | 2,161 | 2,197 | -22 | -1% | 389,200 |
2020/04/06 | 2,210 | 2,249 | 2,180 | 2,219 | -10 | -0.4% | 461,700 |
2020/04/03 | 2,238 | 2,290 | 2,206 | 2,229 | +1 | ±0% | 536,300 |
2020/04/02 | 2,152 | 2,256 | 2,150 | 2,228 | +47 | +2.2% | 593,300 |
2020/04/01 | 2,330 | 2,330 | 2,181 | 2,181 | -17 | -0.8% | 1,206,500 |
2020/03/31 | 2,230 | 2,355 | 2,171 | 2,198 | -1 | ±0% | 1,308,800 |
2020/03/30 | 2,093 | 2,200 | 2,080 | 2,199 | +40 | +1.9% | 670,900 |
2020/03/27 | 1,976 | 2,159 | 1,975 | 2,159 | +197 | +10% | 916,600 |
2020/03/26 | 1,905 | 1,986 | 1,853 | 1,962 | +17 | +0.9% | 709,200 |
2020/03/25 | 1,987 | 1,990 | 1,904 | 1,945 | +13 | +0.7% | 758,600 |
2020/03/24 | 1,982 | 1,982 | 1,864 | 1,932 | -54 | -2.7% | 763,900 |
2020/03/23 | 2,000 | 2,029 | 1,911 | 1,986 | -20 | -1% | 568,700 |
2020/03/19 | 2,025 | 2,040 | 1,966 | 2,006 | +33 | +1.7% | 799,600 |
2020/03/18 | 1,967 | 2,060 | 1,941 | 1,973 | +66 | +3.5% | 1,212,300 |
2020/03/17 | 1,780 | 1,913 | 1,733 | 1,907 | +70 | +3.8% | 817,000 |
2020/03/16 | 1,885 | 1,981 | 1,800 | 1,837 | +72 | +4.1% | 971,900 |
1101~
1150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム